Clinical Trial Update: Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Women With PCOS Undergoing PGT-A [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing euploid blastocyst rates between progestin-primed ovarian stimulation (PPOS) and GnRH antagonist protocols in women with polycy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Snippet

Sponsor: ShangHai Ji Ai Genetics & IVF Institute | Conditions: Preimplantation Genetic Testing, Progestin-primed Ovarian Stimulation | Phase 3 | Status: NOT_YET_RECRUITING